Pliant Therapeutics Insider Trades

PLRX

Track insider trading activity from Pliant Therapeutics executives and directors. See which insiders are buying and selling PLRX stock.

Trades Last 12 Months

PLRX Price

All Insider Trades for Pliant Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kuo Minnie Chief Operating Officer
Holding Value $177k 150,000 shares
Last Trade
Apr 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$326k 245,200 shares
$1.33
$1.18
Coulie Bernard President And CEO
Holding Value $0 0 shares
Last Trade
Apr 17, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.6M 1,951,703 shares
$1.33
$1.18
Cheung Lily Chief Human Resource Officer
Holding Value $0 0 shares
Last Trade
Apr 17, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$302k 226,750 shares
$1.33
$1.18
Cummings Keith Lamont Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Apr 17, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$788k 592,495 shares
$1.33
$1.18
Pyott David E I Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Mccourt Thomas A Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Huh Hoyoung Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Krognes Steve E. Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Knobil Katharine Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Cline Darren S Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Crowell Gayle A Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Curnutte John T Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Hull Hans Chief Business Officer
Holding Value $297k 251,708 shares
Last Trade
Jan 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$895k 80,300 shares
$11.14
$1.18
Lefebvre Eric Chief Medical Officer
Holding Value $283k 240,224 shares
Last Trade
Jan 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 91,300 shares
$11.14
$1.18
Ouimette Mike General Counsel & Corp. Sec'y
Holding Value $125k 105,544 shares
Last Trade
Jan 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$780k 70,000 shares
$11.14
$1.18
Shah Smital Director
Holding Value $31.6k 26,764 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 26,764 shares
$13.06
$1.18
Holding Value $2.17M 1,839,160 shares
Last Trade
Nov 29, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$39M 2,000,000 shares
$19.52
$1.18
Exter Neil Director
Holding Value $17.7k 15,000 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 30,000 shares
$6.80
$1.18
Homcy Charles J Director
Holding Value $15.7k 13,286 shares
Last Trade
Jun 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 13,286 shares
$28.20
$1.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up